Acute intermittent porphyria: response of tachycardia and hypertension to propranolol.
In four young adult patients with acute attacks of acute intermittent porphyria tachycardia and hypertension were prominent features of the illness. Urinary catecholamine excretion was increased in both patients in whom it was measured. The effect of the beta-adrenergic blocking drug propranolol was assessed in each case. The dose varied from 40 to 240 mg daily. A response in the form of a reduction in heart rate and blood pressure was noted in each case, and in one case a marked alleviation of abdominal pain followed administration of the drug.Propranolol, when given in high dosage to rats, did not induce an increase in hepatic delta-aminolaevulic acid synthetase, an enzyme which is raised in human and drug-induced animal porphyria. The use of propranolol is therefore unlikely to aggravate or precipitate an attack of acute intermittent porphyria.
D000624:5-Aminolevulinate Synthetase / Q000032:analysis; D000006:Abdomen, Acute / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008099:Liver / Q000201:enzymology; D008297:Male; D011164:Porphyrias / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy*
D000959:Antihypertensive Agents; D006146:Guanidines; D011433:Propranolol; D000624:5-Aminolevulinate Synthetase